Medical treatment medication is being prescribed in hospitals across the UK for the first time, following a landmark trial by the NHS.
The treatment medication has been developed to treat skin conditions including eczema, psoriasis and Crohn’s disease, and it is being made available by a team of doctors who are trained in treating them.
The trial will involve 1,400 people with a total of 5,000 patients.
Dr Gail Wetherby, head of the NHS National Clinical Trials Centre, said the medication was a breakthrough in treatment and could potentially help thousands of people who had skin conditions and allergies.
“This treatment will help thousands more people get better by reducing the amount of allergens and other potentially harmful bacteria that are present in their skin, as well as helping them to heal better,” she said.
“The treatment may also help those with asthma who have allergies to dust and allergens.”
It may help with sleep disorders, particularly those who have sleep apnea or sleep apathy.
“Dr Wethersby said it was not clear how many people would benefit from the treatment medication.”
We are not sure how many of these people are going to benefit, but it’s certainly a number that we are looking at,” she told BBC Radio 4’s Today programme.”
What we do know is that the more people with these conditions are getting the treatment, the better the results will be.”NHS doctors are currently looking at whether the treatment is safe for people with other conditions, such as cancer and HIV.
Dr Withersby also said it would be important for people to be aware of the benefits of the medication and to use it only when needed.”
People should be aware that it is not for everyone,” she added.
The first trials of the treatment are being carried out in a number of hospitals in London, Birmingham and Manchester.”
I think it’s very important for everyone to take the time to really look at the benefits and the risks, and what the benefits are and what risks are,” Dr Wether told Today.”
You should definitely talk to your GP if you have a family member with allergies, asthma, sleep aplexy or other conditions and to see if they are interested in taking the medication.
“Dr Chris Smith, director of the Cochrane Collaboration, which supports the development of treatments, said it could help many people with skin conditions.”
The National Health Service (NHS) is currently reviewing the trial.”
What it does is stop these people from developing these conditions and the medication is so good at stopping those conditions.”
The National Health Service (NHS) is currently reviewing the trial.